8E0G
Re-refined model of active mu-opioid receptor (PDB 5c1m) as an adduct with BU72
This is a non-PDB format compatible entry.
Summary for 8E0G
Entry DOI | 10.2210/pdb8e0g/pdb |
Descriptor | Mu-type opioid receptor, Nanobody 39, (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate, ... (8 entities in total) |
Functional Keywords | agonist, active state, revised structure, signaling protein-agonist complex, signaling protein/agonist |
Biological source | Mus musculus (house mouse) More |
Total number of polymer chains | 2 |
Total formula weight | 49403.14 |
Authors | Munro, T.A. (deposition date: 2022-08-09, release date: 2023-10-18, Last modification date: 2024-10-30) |
Primary citation | Munro, T.A. Reanalysis of a mu opioid receptor crystal structure reveals a covalent adduct with BU72. Bmc Biol., 21:213-213, 2023 Cited by PubMed Abstract: The first crystal structure of the active μ opioid receptor (μOR) exhibited several unexplained features. The ligand BU72 exhibited many extreme deviations from ideal geometry, along with unexplained electron density. I previously showed that inverting the benzylic configuration resolved these problems, establishing revised stereochemistry of BU72 and its analog BU74. However, another problem remains unresolved: additional unexplained electron density contacts both BU72 and a histidine residue in the N-terminus, revealing the presence of an as-yet unidentified atom. PubMed: 37817141DOI: 10.1186/s12915-023-01689-w PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)